These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 519811)

  • 1. Effect of fasting on the elimination of barbital and phenobarbital in rabbits.
    Kaneniwa N; Hiura M; Funaki T
    Chem Pharm Bull (Tokyo); 1979 Sep; 27(9):2157-62. PubMed ID: 519811
    [No Abstract]   [Full Text] [Related]  

  • 2. Certain aspects of phenobarbital and barbital metabolism.
    Timar M
    Farmaco Prat; 1965 Dec; 20(12):575-80. PubMed ID: 5883897
    [No Abstract]   [Full Text] [Related]  

  • 3. Physical parameters and biological activity of organic compounds. Note III - On the activity coefficient of some barbiturates.
    Avico U; Signoretti EC; Di Francesco R; Zuccaro P; Cingolani E
    Boll Chim Farm; 1976 Mar; 115(3):242-53. PubMed ID: 6038
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolism of some barbiturate derivatives to epoxides in rat liver microsomes.
    Pachecka J; Słojkowska Z; Opioła E
    Acta Pol Pharm; 1979; 36(5):613-7. PubMed ID: 44961
    [No Abstract]   [Full Text] [Related]  

  • 5. Heteroassociation of O- and N-isopropyl derivatives of barbital and phenobarbital with 9-ethyladenine.
    Gentric E; Menez JF; Lauransan J; Bardou LG; Saumagne P
    Chem Biol Interact; 1985 Jun; 54(1):117-25. PubMed ID: 4017102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Determination of barbiturates from biological material].
    Pracharová M; Pestálovă M; Dubský H; Hána K
    Soud Lek; 1975 Aug; 20(3):38-42. PubMed ID: 1860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfiram enhances pharmacological activity of barbital and impairs its urinary elimination.
    Sharkawi M; Cianflone D
    Science; 1978 Aug; 201(4355):543-4. PubMed ID: 663674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The metabolism of barbiturates.
    MAYNERT EW; VAN DYKE HB
    Pharmacol Rev; 1949; 1(2):217-42. PubMed ID: 18137904
    [No Abstract]   [Full Text] [Related]  

  • 9. Physical dependence to barbital compared to pentobarbital. IV. Influence of elimination kinetics.
    Boisse NR; Okamoto M
    J Pharmacol Exp Ther; 1978 Mar; 204(3):526-40. PubMed ID: 564953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sample size effect on induction time measurement of barbital tolerance development in male mice.
    Baccus AL; Risher DL; Townsend SW; Ewell CW; Proctor CD
    Q Natl Dent Assoc; 1980 Apr; 38(3):107-16. PubMed ID: 6933583
    [No Abstract]   [Full Text] [Related]  

  • 11. The metabolism of radioactive pentobarbital in mice.
    ROTH LJ; LEIFER E
    J Biol Chem; 1949 Apr; 178(2):963-5. PubMed ID: 18117018
    [No Abstract]   [Full Text] [Related]  

  • 12. The effect of alpha-tocopherol deficiency on the pharmacokinetics and pharmacological effect of barbital.
    Meshali MM; Nightingale CH
    Life Sci; 1976 Jul; 19(2):163-74. PubMed ID: 957863
    [No Abstract]   [Full Text] [Related]  

  • 13. Social isolation and tolerance development to sodium barbital in mice.
    Faggin BM; Palermo-Neto J
    Braz J Med Biol Res; 1985; 18(2):223-6. PubMed ID: 3830284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetration of 14C-antipyrine and 14C-barbital into the choroid plexus and cerebrospinal fluid of the rat in vivo.
    Johanson CE; Woodbury DM
    Exp Brain Res; 1977 Oct; 30(1):65-74. PubMed ID: 22452
    [No Abstract]   [Full Text] [Related]  

  • 15. Regional distribution of barbital in the brain of mice during the development of tolerance and physical dependence.
    Lin SC; Sutherland VC
    Res Commun Chem Pathol Pharmacol; 1977 Oct; 18(2):215-31. PubMed ID: 562525
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subepithelial capillary blood flow estimated from blood-to-lumen flux of barbital in ileum of rats.
    Csáky TZ; Varga F
    Am J Physiol; 1975 Sep; 229(3):549-52. PubMed ID: 1211448
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Absorption and distribution of sodium [2-14C]barbital in tissues of normal and dystrophic mice.
    Stephens HR; Nadeau D; Sandborn EB
    Can J Physiol Pharmacol; 1978 Feb; 56(1):76-82. PubMed ID: 638861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of complex formation on interfacial transfer rate of drugs across two liquid phases (author's transl)].
    Kiryu S; Tateyama T; Iguchi S
    Yakugaku Zasshi; 1982 Jan; 102(2):207-10. PubMed ID: 7108751
    [No Abstract]   [Full Text] [Related]  

  • 19. Influence of the dopamine-beta-hydroxylase inhibitor FLA 63 on the disposition of barbitone in the mouse.
    Sharkawi M
    J Pharm Pharmacol; 1979 May; 31(5):340-1. PubMed ID: 37309
    [No Abstract]   [Full Text] [Related]  

  • 20. Barbital N-glucoside is not detected as a urinary excretion product of barbital in humans.
    Soine WH; Soine PJ; England TM
    J Pharm Biomed Anal; 1991; 9(9):747-52. PubMed ID: 1821152
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.